Related Experiment Video
Updated: Jul 26, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Tuberculosis: current challenges and beyond
Raquel Villar-Hernández1,2,3, Arash Ghodousi4,3, Olha Konstantynovska5,3
1Institut d'Investigació Germans Trias i Pujol, Barcelona, Spain.
Tuberculosis (TB) remains a global health crisis despite being preventable and curable. Urgent, multi-sectoral action and research investment are crucial to combat TB and overcome setbacks from pandemics and conflicts.
Area of Science:
- Global Health
- Infectious Diseases
- Public Health Policy
Background:
- Tuberculosis (TB) is a major global health threat and the second leading cause of infectious disease death.
- Progress in reducing TB incidence and mortality has been slow and hampered by the COVID-19 pandemic.
- Recent global conflicts exacerbate the challenge of controlling the TB burden.
Purpose of the Study:
- To highlight the persistent global threat of tuberculosis.
- To underscore the impact of recent global events on TB control efforts.
- To advocate for intensified and innovative strategies to end TB.
Main Methods:
- This study is a review and analysis of the current global TB situation.
- It synthesizes data on TB incidence, mortality, and progress towards End TB Strategy targets.
- It examines the impact of external factors like pandemics and conflicts on TB control.
Main Results:
- Global efforts have led to slow decreases in TB incidence and mortality.
- The COVID-19 pandemic has negatively impacted TB control programs.
- Ongoing conflicts pose a further threat to TB reduction efforts.
- Most End TB Strategy targets are currently off track.
Conclusions:
- Ending tuberculosis requires urgent, global, and multi-sectoral commitment.
- Significant investments in research and innovation are essential.
- Equitable and rapid implementation of new strategies is critical to regain momentum.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Microorganisms in Medicine and Therapeutics

